Thermo Fisher Scientific
$665.60Change from previous close: −1.40%Absolute change: −$9.45
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 44,556 | 42,879 | 42,857 | 44,915 | 39,211 |
| Cost of revenue | 26,254 | 25,130 | 25,757 | 25,944 | 19,573 |
| Gross profit | 18,302 | 17,749 | 17,100 | 18,971 | 19,638 |
| Selling, general and administrative | 8,527 | 8,602 | 8,440 | 8,940 | 7,857 |
| Research and development | 1,397 | 1,390 | 1,337 | 1,471 | 1,406 |
| Operating income | 8,358 | 7,727 | 7,322 | 8,560 | 10,372 |
| EBIT | 8,358 | 7,727 | 7,322 | 8,560 | 10,372 |
| EBITDA | 11,138 | 10,835 | 10,728 | 11,941 | 12,964 |
| Interest expense | 1,419 | 1,390 | 1,375 | 726 | 536 |
| Pre-tax income | 7,268 | 6,995 | 6,239 | 7,663 | 8,837 |
| Income tax | 547 | 657 | 284 | 703 | 1,109 |
| Net income | 6,704 | 6,335 | 5,995 | 6,950 | 7,725 |
| Net income to common shareholders | 6,704 | 6,335 | 5,995 | 6,950 | 7,725 |
| Basic EPS | 17.78 | 16.58 | 15.53 | 17.73 | 19.61 |
| Diluted EPS | 17.74 | 16.53 | 15.45 | 17.63 | 19.46 |
| Average shares (basic) | 377 | 382 | 386 | 392 | 394 |
| Average shares (diluted) | 378 | 383 | 388 | 394 | 397 |
| Dividend per share | 1.72 | 1.56 | 1.40 | 1.20 | 1.04 |